Bovilis Ringvac

Země: Velká Británie

Jazyk: angličtina

Zdroj: VMD (Veterinary Medicines Directorate)

Aktivní složka:

Trichophyton verrucosum

Dostupné s:

MSD Animal Health UK Limited

ATC kód:

QI02AP01

INN (Mezinárodní Name):

Trichophyton verrucosum

Léková forma:

Lyophilisate and solvent for suspension for injection

Druh předpisu:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutické skupiny:

Cattle

Terapeutické oblasti:

Live Fungal Vaccine

Stav Autorizace:

Authorized

Datum autorizace:

2005-09-23

Charakteristika produktu

Revised: June 2020
AN: 00218/2020
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Bovilis Ringvac
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_Active substance(s)_
Per ml of reconstituted product:
_Trichophyton verrucosum_

7 x 10
6
and

21 x 10
6
viable
microconidia strain LTF-130.
3.
PHARMACEUTICAL FORM
Lyophilisate for suspension for injection
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE SPECIFYING THE TARGET SPECIES
For active immunisation of cattle to reduce clinical signs of ringworm
caused by
_Trichophyton verrucosum_. (prophylactic dose) and to shorten the
recovery time
of infected cattle showing clinical signs of ringworm (therapeutic
dose).
Onset of immunity has been demonstrated at 3 weeks after completion of
the
recommended course.
The duration of protection has not been determined but experience of
use in the
field suggests that after the recommended course has been completed
cattle
continue to be protected without re-vaccination.
4.3
CONTRAINDICATIONS
Do not vaccinate cattle already infected with or in the incubation of
an infection
with _ Trichophyton verrucosum_ with the prophylactic dose. In such
cases,
animals show signs of the disease which could be severe.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: June 2020
AN: 00218/2020
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE, INCLUDING SPECIAL PRECAUTIONS TO BE TAKEN
BY
THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS.
Special precautions for use in animals
Occasional hypersensitivity reactions may occur. In such cases
appropriate
treatment with e.g. adrenaline should be given without delay.
Use fresh sterilised equipment for each injection.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Immuno-suppressed individuals should not use the product.
In case of accidental self-injection, seek medical advice and show the
package
insert or label to the physician.
4.6
ADVERSE REACTIONS (FREQUENCY AND SE